PMID- 29124871 OWN - NLM STAT- MEDLINE DCOM- 20181108 LR - 20181108 IS - 1520-7560 (Electronic) IS - 1520-7552 (Linking) VI - 34 IP - 2 DP - 2018 Feb TI - Low triglyceride as a marker for increased risk of cardiovascular diseases in patients with long-term type 2 diabetes: A cross-sectional survey in China. LID - 10.1002/dmrr.2960 [doi] AB - BACKGROUND: There are inconsistent findings regarding associations between triglyceride levels and cardiovascular disease (CVD) in type 2 diabetes mellitus (T2DM). This study aimed to test whether the association between triglycerides and CVD depends upon duration of diabetes. METHODS: From April 1, 2012, to June 30, 2012, we conducted a cross-sectional survey of 223 612 patients with T2DM from 630 hospitals in China. Cardiovascular disease was defined as having either prior coronary heart disease or stroke, or diabetic foot. Binary logistic regression was used to estimate odds ratios of triglyceride for CVD. Relative excess risk due to interaction, attributable proportion due to interaction, and synergy index were used to estimate effect size of additive interaction between low triglyceride, ie, <1.7 mmol/L, and duration of diabetes, ie, >/=15 years. RESULTS: Among 223 612 T2DM patients, 31 898 (14.27%) suffered from CVD. A low level of triglyceride was associated with decreased risk of CVD (univariable OR, 0.91, 95% CI, 0.88-0.93; multivariable OR, 0.94, 95% CI, 0.92-0.97) among patients with <15 years of duration of diabetes but increased risk of CVD (univariable OR, 1.12, 95% CI, 1.04-1.21; multivariable OR, 1.18, 95% CI, 1.09-1.27) among those patients with 15 and more years of duration of diabetes with significant additive interactions (relative excess risk due to interaction, 0.39, 95% CI, 0.25-0.52; attributable proportion due to interaction, 0.20, 95% CI, 0.14-0.27; and synergy index, 1.80, 95% CI, 1.43-2.28). CONCLUSIONS: Whereas a high triglyceride level was associated with increased risk of CVD in short-term T2DM, low triglyceride was associated with increased CVD risk in long-term T2DM. Low triglyceride may be a marker of CVD risk in Chinese patients with long-term T2DM. CI - Copyright (c) 2017 John Wiley & Sons, Ltd. FAU - Ren, Yanfeng AU - Ren Y AD - Department of Epidemiology and Biostatistics, School of Public Health, Tianjin Medical University, Tianjin, China. AD - Department of Health Statistics, School of Public Health and Management, Weifang Medical University, Shandong, China. FAU - Ren, Qian AU - Ren Q AD - Department of Endocrinology, Peking University People's Hospital, Beijing, China. FAU - Lu, Juming AU - Lu J AD - Department of Endocrinology, Chinese PLA General Hospital, Beijing, China. FAU - Guo, Xiaohui AU - Guo X AD - Department of Endocrinology, Peking University First Hospital, Beijing, China. FAU - Huo, Xiaoxu AU - Huo X AD - Department of Epidemiology and Biostatistics, School of Public Health, Tianjin Medical University, Tianjin, China. FAU - Ji, Linong AU - Ji L AUID- ORCID: 0000-0002-3262-2168 AD - Department of Endocrinology, Peking University People's Hospital, Beijing, China. FAU - Yang, Xilin AU - Yang X AUID- ORCID: 0000-0002-9462-7992 AD - Department of Epidemiology and Biostatistics, School of Public Health, Tianjin Medical University, Tianjin, China. LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20171128 PL - England TA - Diabetes Metab Res Rev JT - Diabetes/metabolism research and reviews JID - 100883450 RN - 0 (Biomarkers) RN - 0 (Triglycerides) SB - IM MH - Aged MH - Biomarkers/*blood MH - Cardiovascular Diseases/blood/*diagnosis/epidemiology/etiology MH - China/epidemiology MH - Cross-Sectional Studies MH - Diabetes Mellitus, Type 2/*complications MH - Female MH - Follow-Up Studies MH - Humans MH - Male MH - Middle Aged MH - Prognosis MH - Surveys and Questionnaires MH - Time Factors MH - Triglycerides/*blood OTO - NOTNLM OT - Chinese OT - cardiovascular complications OT - duration OT - triglyceride OT - type 2 diabetes EDAT- 2017/11/11 06:00 MHDA- 2018/11/09 06:00 CRDT- 2017/11/11 06:00 PHST- 2017/02/10 00:00 [received] PHST- 2017/10/07 00:00 [revised] PHST- 2017/10/30 00:00 [accepted] PHST- 2017/11/11 06:00 [pubmed] PHST- 2018/11/09 06:00 [medline] PHST- 2017/11/11 06:00 [entrez] AID - 10.1002/dmrr.2960 [doi] PST - ppublish SO - Diabetes Metab Res Rev. 2018 Feb;34(2). doi: 10.1002/dmrr.2960. Epub 2017 Nov 28.